Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Previous data have demonstrated that administration of inflammatory cytokines or their inducers leads to altered basal ganglia function associated with reduced psychomotor speed. Decreased psychomotor speed, referred to clinically as psychomotor retardation, is a cardinal symptom of major depressive disorder (MDD) and has been associated with poor antidepressant treatment response. We therefore examined the association between plasma inflammatory markers and psychomotor speed in ninety-three un-medicated patients with MDD. Psychomotor speed was assessed by a range of neuropsychological tests from purely motor tasks (e.g. movement latency and finger tapping) to those that involved motor activity with increasing cognitive demand and cortical participation (e.g. Trails A and Digit Symbol Substitution Task (DSST)). Linear regression analyses were performed to determine the relationship of inflammatory markers and psychomotor task performance controlling for age, race, sex, education, body mass index, and severity of depression. MDD patients exhibited decreased psychomotor speed on all tasks relative to normative standards. Increased IL-6 was associated with decreased performance on simple and choice movement time tasks, whereas MCP-1 was associated with decreased performance on the finger tapping task and DSST. IL-10 was associated with increased performance on the DSST. In an exploratory principle component analysis including all psychomotor tasks, IL-6 was associated with the psychomotor speed factor. Taken together, the data indicate that a peripheral inflammatory profile including increased IL-6 and MCP-1 is consistently associated with psychomotor speed in MDD. These data are consistent with data demonstrating that inflammation can affect basal ganglia function, and indicate that psychomotor speed may be a viable outcome variable for anti-inflammatory therapies in depression and other neuropsychiatric disorders with increased inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · cited 4×
“Samples were obtained in chilled EDTA-coated tubes and spun at 1000 g for 15 min at 4 C, and plasma was collected and stored at 80 C for later batched analysis of CRP and the inflammatory cytokines interleukin (IL)-6, IL-1beta and tumor necrosis factor (TNF) and their soluble receptors as well as MCP1, all of which ha…”
BackgroundMethodInfluentialProcedures for Detecting Outlying Observations in Samples
Grubbs, F. E. (1969) · Technometrics · doi:10.1080/00401706.1969.10490657 · Cited by 4,105 · cited 1×
“Similarly, IL-6 antibodies have been shown to reverse cytokine-induced psychomotor slowing in rodents (Harden et al., 2006; Pang et al., 2006).”
BackgroundThe role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · cited 1×
“…(CRP), and chemokines (e.g. monocyte chemotactic protein (MCP-1)) and adhesion molecules have been found to be increased in the peripheral blood and cerebrospinal fluid of a subgroup of patients with MDD (Dowlati et al., 2010; Goldsmith et al., 2016; Miller and Raison, 2015; Zunszain et al., 2013).”
BackgroundSelf-citationCytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Self-citationMore powerful procedures for multiple significance testing
Hochberg, Y., & Benjamini, Y. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090710 · Cited by 2,715 · cited 1×
“In order to control for multiple comparisons, a Benjamini and Hochberg approach (Hochberg and Benjamini, 1990) was employed.”
MethodThe brain reward circuitry in mood disorders
Russo, S. J., & Nestler, E. J. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3381 · Cited by 1,870 · cited 1×
“Furthermore, both the ventral striatum and the vmPFC receive significant dopaminergic innervation (Felger and Miller, 2012; Russo and Nestler, 2013).”
BackgroundGoldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683 · cited 2×
“monocyte chemotactic protein (MCP-1)) and adhesion molecules have been found to be increased in the peripheral blood and cerebrospinal fluid of a subgroup of patients with MDD (Dowlati et al., 2010; Goldsmith et al., 2016; Miller and Raison, 2015; Zunszain et al., 2013).”
BackgroundSelf-citationRaison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617 · cited 1×
“Work from our own group indicates that individuals with high baseline CRP showed decreased psychomotor retardation (as measured by item 8, asking about psychomotor retardation, on the HAM-D Scale) following treatment with infliximab versus placebo (Raison et al., 2013).”
BackgroundSelf-citationCytokine-Associated Emotional and Cognitive Disturbances in Humans
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.445 · Cited by 1,365 · cited 2×
“…such as endotoxin and typhoid vaccination have been shown to lead to depressive symptoms including psychomotor retardation as well as objective measures of psychomotor slowing (Brydon et al., 2008; Capuron et al., 2002; Musselman et al., 2001; Reichenberg et al., 2001; Yirmiya et al., 2000).”
BackgroundCapuron, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00407-9 · Cited by 797 · cited 2×
“…such as endotoxin and typhoid vaccination have been shown to lead to depressive symptoms including psychomotor retardation as well as objective measures of psychomotor slowing (Brydon et al., 2008; Capuron et al., 2002; Musselman et al., 2001; Reichenberg et al., 2001; Yirmiya et al., 2000).”
BackgroundMethodPsychomotor symptoms of depression
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.1.4 · Cited by 662 · cited 1×
“Nevertheless, the study benefitted from the availability of normative data for all tasks, and in each case, the depressed population exhibited the expected reduced psychomotor performance that has been previously described (Sobin and Sackeim, 1997).”
BackgroundFelger, J. C., Li, Z., Haroon, E., Woolwine, B. J., Jung, M. Y., Hu, X., & Miller, A. H. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.168 · Cited by 620
Self-citationInflammation-Induced Anhedonia: Endotoxin Reduces Ventral Striatum Responses to Reward
Eisenberger, N. I., Berkman, E. T., Inagaki, T. K., Rameson, L. T., Mashal, N. M., & Irwin, M. R. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.010 · Cited by 596 · cited 2×
“Relevant to the mechanism by which inflammation may influence psychomotor performance, inflammation has been shown to alter neural activity and dopamine metabolism in basal ganglia regions including the dorsal striatum as assessed by a variety of neuroimaging strategies following several inflammatory stimuli including…”
MethodInfluentialTorres-Platas, S. G., Cruceanu, C., Chen, G. G., Turecki, G., & Mechawar, N. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.05.007 · Cited by 545 · cited 1×
“MCP-1 has also been shown to attract monocytes to the brain during stress and has exhibited increased expression in the brains of suicide victims (Torres-Platas et al., 2014).”
BackgroundFrenois, F., Moreau, M., O’Connor, J., Lawson, M., Micon, C., Lestage, J., Kelley, K. W., Dantzer, R., & Castanon, N. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.03.005 · Cited by 438 · cited 2×
“Although no study has reported a significant relationship between MCP-1 and psychomotor slowing, it has been associated with cognitive impairment in multiple clinical populations including first episode psychosis (Martinez-Cengotitabengoa et al., 2012), mild cognitive impairment and early stage Alzheimer’s Disease (Ga…”
BackgroundCapuron, L., Pagnoni, G., Drake, D. F., Woolwine, B. J., Spivey, J. R., Crowe, R. J., Votaw, J. R., Goodman, M. M., & Miller, A. H. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2094 · Cited by 382 · cited 2×
“Relevant to the mechanism by which inflammation may influence psychomotor performance, inflammation has been shown to alter neural activity and dopamine metabolism in basal ganglia regions including the dorsal striatum as assessed by a variety of neuroimaging strategies following several inflammatory stimuli including…”
MethodInfluentialSelf-citationBrydon, L., Harrison, N. A., Walker, C., Steptoe, A., & Critchley, H. D. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.12.007 · Cited by 381 · cited 7×
“Similarly, healthy individuals given typhoid vaccination showed increased activity in the basal ganglia using fMRI, which was associated with both increases in peripheral blood IL-6 and psychomotor slowing (Brydon et al., 2008).”
BackgroundMethodResultInfluentialPro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy
Sutcigil, L., Oktenli, C., Musabak, U., Bozkurt, A., Cansever, A., Uzun, O., Sanisoglu, S. Y., Yesilova, Z., Ozmenler, N., Ozsahin, A., et al. (2007) · Clinical and Developmental Immunology · doi:10.1155/2007/76396 · Cited by 315
An fMRI study of cytokine-induced depressed mood and social pain: The role of sex differences
Eisenberger, N. I., Inagaki, T. K., Rameson, L. T., Mashal, N. M., & Irwin, M. R. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.04.040 · Cited by 313 · cited 1×
“Based on previous work showing that women may respond differentially to inflammatory stimuli (Eisenberger et al., 2009; Moieni et al., 2015), we performed exploratory statistical analyses on males and females separately for these tasks.”
MethodA detailed examination of cytokine abnormalities in Major Depressive Disorder
Simon, N. M., McNamara, K., Chow, C. W., Maser, R. S., Papakostas, G. I., Pollack, M. H., Nierenberg, A. A., Fava, M., & Wong, K. K. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.06.004 · Cited by 286 · cited 2×
“…we examined a variety of tasks assessing various degrees of motor control as well as a full panel of inflammatory cytokines and their receptors in addition to the chemokine, MCP-1, previously shown to be elevated in MDD subjects (Piletz et al., 2009; Simon et al., 2008; Sutcigil et al., 2007).”
BackgroundIllness, Cytokines, and Depression
YIRMIYA, R., POLLAK, Y., MORAG, M., REICHENBERG, A., BARAK, O., AVITSUR, R., SHAVIT, Y., OVADIA, H., WEIDENFELD, J., MORAG, A., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05412.x · Cited by 284 · cited 2×
“…such as endotoxin and typhoid vaccination have been shown to lead to depressive symptoms including psychomotor retardation as well as objective measures of psychomotor slowing (Brydon et al., 2008; Capuron et al., 2002; Musselman et al., 2001; Reichenberg et al., 2001; Yirmiya et al., 2000).”
BackgroundWestin, K., Buchhave, P., Nielsen, H., Minthon, L., Janciauskiene, S., & Hansson, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030525 · Cited by 277
Moieni, M., Irwin, M. R., Jevtic, I., Olmstead, R., Breen, E. C., & Eisenberger, N. I. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.17 · Cited by 273 · cited 2×
“Concentrations of cytokines and their soluble receptors as well as the chemokine MCP-1 were assessed in duplicate using high sensitivity multiplex bead-based assays (R& D Systems) and analyzed on a MAGPIX CCD imager (Luminex) as previously described (Felger et al., 2015b; Moieni et al., 2015).”
MethodAas, M., Dazzan, P., Mondelli, V., Melle, I., Murray, R. M., & Pariante, C. M. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00182 · Cited by 230 · cited 2×
“…inform relative immune and neurocognitive endpoints relevant to the testing of anti-inflammatory treatments in patients with MDD and other psychiatric disorders with increased inflammation and impaired psychomotor performance, such as schizophrenia (Aas et al., 2014; Bortolato et al., 2015).”
BackgroundBasal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy
Capuron, L., Pagnoni, G., Demetrashvili, M. F., Lawson, D. H., Fornwalt, F. B., Woolwine, B., Berns, G. S., Nemeroff, C. B., & Miller, A. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301362 · Cited by 229 · cited 1×
“…metabolism using 18F-fluorodeoxyglucose in IFN-alpha-treated patients showed increased glucose metabolism in basal ganglia regions believed to be secondary to impaired dopamine-mediated inhibition of oscillatory burst activity in basal ganglia nuclei (Capuron et al., 2007; Juengling et al., 2000).”
MethodSelf-citationFelger, J. C., Mun, J., Kimmel, H. L., Nye, J. A., Drake, D. F., Hernandez, C. R., Freeman, A. A., Rye, D. B., Goodman, M. M., Howell, L. L., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.115 · Cited by 214 · cited 1×
“Moreover, IFN-alpha-induced changes in dopamine release were reversed by administration of the dopamine precursor levodopa (Felger et al., 2015a; Felger et al., 2013).”
BackgroundSelf-citationSerum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer’s disease
Galimberti, D., Fenoglio, C., Lovati, C., Venturelli, E., Guidi, I., Corrà, B., Scalabrini, D., Clerici, F., Mariani, C., Bresolin, N., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.007 · Cited by 209 · cited 1×
“…(CRP), and chemokines (e.g. monocyte chemotactic protein (MCP-1)) and adhesion molecules have been found to be increased in the peripheral blood and cerebrospinal fluid of a subgroup of patients with MDD (Dowlati et al., 2010; Goldsmith et al., 2016; Miller and Raison, 2015; Zunszain et al., 2013).”
BackgroundMartinot, M.-L. P., Bragulat, V., Artiges, E., Dollé, F., Hinnen, F., Jouvent, R., & Martinot, J.-L. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.314 · Cited by 194
Clinical and psychometric correlates of dopamine D2 binding in depression
SHAH, P. J., OGILVIE, A. D., GOODWIN, G. M., & EBMEIER, K. P. (1997) · Psychological Medicine · doi:10.1017/s0033291797005382 · Cited by 170
Haroon, E., Woolwine, B. J., Chen, X., Pace, T. W., Parekh, S., Spivey, J. R., Hu, X. P., & Miller, A. H. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.25 · Cited by 154
Self-citationPrefrontal cortical hypometabolism during low-dose interferon alpha treatment
Juengling, F. D., Ebert, D., Gut, O., Engelbrecht, M. A., Rasenack, J., Nitzsche, E. U., Bauer, J., & Lieb, K. (2000) · Psychopharmacology · doi:10.1007/s002130000549 · Cited by 149
Bortolato, B., F. Carvalho, A., K. Soczynska, J., I. Perini, G., & S. McIntyre, R. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150630171433 · Cited by 142
Majer, M., Welberg, L. A. M., Capuron, L., Pagnoni, G., Raison, C. L., & Miller, A. H. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.12.009 · Cited by 124
Self-citationTreatment response and cognitive impairment in major depression: Association with C-reactive protein
Chang, H. H., Lee, I. H., Gean, P. W., Lee, S.-Y., Chi, M. H., Yang, Y. K., Lu, R.-B., & Chen, P. S. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.07.239 · Cited by 120
Raison, C. L., Rye, D. B., Woolwine, B. J., Vogt, G. J., Bautista, B. M., Spivey, J. R., & Miller, A. H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.019 · Cited by 116 · cited 9×
“Psychomotor performance was measured by 1) the Reaction Time Task of the Cambridge Neuropsychological Test Automated Battery (CANTAB), that includes simple and five-choice reaction time segments and provides distinctions between movement latencies (simple and choice movement time – SMT and CMT, respectively) and react…”
MethodInfluentialSelf-citationPsychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients
Taylor, B. P., Bruder, G. E., Stewart, J. W., McGrath, P. J., Halperin, J., Ehrlichman, H., & Quitkin, F. M. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.73 · Cited by 109 · cited 2×
“, 2002), and has been associated with a poor response to antidepressant treatment (Bruder et al., 2014; Taylor et al., 2006).”
BackgroundCognitive Dysfunction in Depression – Pathophysiology and Novel Targets
Carvalho, A., Miskowiak, K., Hyphantis, T., Kohler, C., Alves, G., Bortolato, B., G. Sales, P., Machado-Vieira, R., Berk, M., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203627 · Cited by 107
Acute Changes in Striatal Microstructure Predict the Development of Interferon-Alpha Induced Fatigue
Dowell, N. G., Cooper, E. A., Tibble, J., Voon, V., Critchley, H. D., Cercignani, M., & Harrison, N. A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.015 · Cited by 74
Recovery after l-DOPA treatment in peginterferon and ribavirin induced parkinsonism
Bersano, A., Aghemo, A., Rumi, M. G., Ballabio, E., Candelise, L., & Colombo, M. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.10.003 · Cited by 26
Cited by
What does plasma CRP tell us about peripheral and central inflammation in depression?
Felger, J. C., Haroon, E., Patel, T. A., Goldsmith, D. R., Wommack, E. C., Woolwine, B. J., Le, N.-A., Feinberg, R., Tansey, M. G., & Miller, A. H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0096-3 · Cited by 448
Self-citationInflammation Effects on Motivation and Motor Activity: Role of Dopamine
Felger, J. C., & Treadway, M. T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 442
Self-citationImaging the Role of Inflammation in Mood and Anxiety-related Disorders
Felger, J. C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171123201142 · Cited by 427
Self-citationTherapeutic Implications of Brain–Immune Interactions: Treatment in Translation
Miller, A. H., Haroon, E., & Felger, J. C. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.167 · Cited by 152
Self-citationInteroception and Inflammation in Psychiatric Disorders
Savitz, J., & Harrison, N. A. (2018) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.12.011 · Cited by 126
“This association between IL-6 and poorer performance on simple and choice movement time tasks has subsequently been replicated in MDD patients (94).”
Metadata
- Authors
- Goldsmith, D. R., Haroon, E., Woolwine, B. J., Jung, M. Y., Wommack, E. C., Harvey, P. D., Treadway, M. T., Felger, J. C., & Miller, A. H.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 56
- Pages
- 281-288
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W2329098399
- Cited by
- 140
- References
- 40
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.